{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:50:08Z","timestamp":1777719008587,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12020-014-0426-4","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T07:36:48Z","timestamp":1412667408000},"page":"286-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial"],"prefix":"10.1007","volume":"49","author":[{"given":"Ashraf","family":"Moini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahia","family":"Kanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reihaneh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,8]]},"reference":[{"key":"426_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"13","author":"S Franks","year":"1995","unstructured":"S. Franks, Polycystic ovary syndrome. N. Engl. J. Med. 13, 853\u2013861 (1995)","journal-title":"N. Engl. J. Med."},{"key":"426_CR2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/09513590.2012.752455","volume":"29","author":"SE Kedikova","year":"2013","unstructured":"S.E. Kedikova, M.M. Sirakov, M.V. Boyadzhieva, Leptin levels and adipose tissue percentage in adolescents with polycystico vary syndrome. Gynecol. Endocrinol. 29, 384\u2013387 (2013)","journal-title":"Gynecol. Endocrinol."},{"key":"426_CR3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0032-1328878","volume":"30","author":"RS Legro","year":"2012","unstructured":"R.S. Legro, Obesity and PCOS: implications for diagnosis and treatment. Semin. Reprod. Med. 30, 496\u2013506 (2012)","journal-title":"Semin. Reprod. Med."},{"key":"426_CR4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/07853890410035296","volume":"36","author":"AK Schr\u00f6der","year":"2004","unstructured":"A.K. Schr\u00f6der, S. Tauchert, O. Ortmann, K. Diedrich, J.M. Weiss, Insulin resistance in patients with polycystic ovary syndrome. Ann. Med. 36, 426\u2013439 (2004)","journal-title":"Ann. Med."},{"key":"426_CR5","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"R.S. Legro, A.R. Kunselman, W.C. Dodson, A. Dunaif, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165\u2013169 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"426_CR6","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.2174\/13816128112092482","volume":"18","author":"AB Motta","year":"2012","unstructured":"A.B. Motta, The role of obesity in the development of polycystic ovary syndrome. Current Pharm. Des. 18, 2482\u20132491 (2012)","journal-title":"Current Pharm. Des."},{"key":"426_CR7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","volume":"113","author":"R Pasquali","year":"2006","unstructured":"R. Pasquali, A. Gambineri, U. Pagotto, The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 113, 1148\u20131159 (2006)","journal-title":"BJOG"},{"key":"426_CR8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","volume":"18","author":"HF Escobar-Morreale","year":"2007","unstructured":"H.F. Escobar-Morreale, J.L. San Milla\u00b4n, Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol. Metab. 18, 266\u2013272 (2007)","journal-title":"Trends Endocrinol. Metab."},{"key":"426_CR9","first-page":"59","volume":"38","author":"P Ravn","year":"2013","unstructured":"P. Ravn, A.G. Haugen, D. Glintborg, Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss. Minerva Endocrinol. 38, 59\u201376 (2013)","journal-title":"Minerva Endocrinol."},{"key":"426_CR10","first-page":"1470","volume":"84","author":"MM Huber-Buchholz","year":"1999","unstructured":"M.M. Huber-Buchholz, D.G. Carey, R.J. Norman, Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J. Clin. Endocrinol. Metab. 84, 1470\u20131474 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"426_CR11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/0026-0495(92)90111-M","volume":"41","author":"M Parillo","year":"1992","unstructured":"M. Parillo, A.A. Rivellese, A.V. Ciardullo, B. Capaldo, A. Giacco, S. Genovese et al., A highmonounsaturated-fat\/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulindependent diabetic patients. Metabolism 41, 1373\u20131378 (1992)","journal-title":"Metabolism"},{"key":"426_CR12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM198809293191304","volume":"319","author":"A Garg","year":"1988","unstructured":"A. Garg, A. Bonanome, S.M. Grundy, Z. Zhang, R.H. Unger, Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 319, 829\u2013834 (1988)","journal-title":"N. Engl. J. Med."},{"key":"426_CR13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2005.08.045","volume":"85","author":"CC Douglas","year":"2006","unstructured":"C.C. Douglas, B.A. Gower, B.E. Darnell, F. Ovalle, R.A. Oster, R. Azziz, Role of diet in the treatment of polycystic ovary syndrome. Fertil. Steril. 85, 679\u2013688 (2006)","journal-title":"Fertil. Steril."},{"key":"426_CR14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archinte.160.9.1321","volume":"160","author":"SB Heymsfield","year":"2000","unstructured":"S.B. Heymsfield, K.R. Segal, J. Hauptman, C.P. Lucas, M.N. Boldrin, A. Rissanen, J.P.H. Wilding, L. Sj\u00f6str\u00f6m, Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch. Intern. Med. 160, 1321\u20131326 (2000)","journal-title":"Arch. Intern. Med."},{"key":"426_CR15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2004-0176","volume":"90","author":"V Jayagopal","year":"2005","unstructured":"V. Jayagopal, E.S. Kilpatrick, S. Holding, P.E. Jennings, S.L. Atkin, Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 90, 729\u2013733 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"426_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3810\/pgm.2013.09.2692","volume":"125","author":"G Bray","year":"2013","unstructured":"G. Bray, M. Look, D. Ryan, Treatment of the obese patient in primary care: targeting and meeting goals and expectations. Postgrad. Med. 125, 67\u201377 (2013)","journal-title":"Postgrad. Med."},{"key":"426_CR17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cen.12305","volume":"80","author":"D Panidis","year":"2014","unstructured":"D. Panidis, K. Tziomalos, E. Papadakis, P. Chatzis, E.A. Kandaraki, E.A. Tsourdi, I. Katsikis, The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome. Clin. Endocrinol. 80, 432\u2013438 (2014)","journal-title":"Clin. Endocrinol."},{"key":"426_CR18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/humrep\/den454","volume":"24","author":"M Metwally","year":"2009","unstructured":"M. Metwally, S. Amer, T.C. Li, W.L. Ledger, An RCT of metformin versus orlistatfor the management of obese anovulatory women. Hum. Reprod. 24, 966\u2013975 (2009)","journal-title":"Hum. Reprod."},{"key":"426_CR19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/dep049","volume":"24","author":"R Homburg","year":"2009","unstructured":"R. Homburg, Androgen circle of polycystic ovary syndrome. Hum. Reprod. 24, 1548\u20131555 (2009)","journal-title":"Hum. Reprod."},{"key":"426_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10815-011-9564-2","volume":"28","author":"S Ghandi","year":"2011","unstructured":"S. Ghandi, A. Aflatoonian, N. Tabibnejad, M.H. SojoodiMoghaddam, The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study. J. Assist. Reprod. Genet. 28, 591\u2013596 (2011)","journal-title":"J. Assist. Reprod. Genet."},{"key":"426_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2265.2008.03309.x","volume":"70","author":"LW Cho","year":"2009","unstructured":"L.W. Cho, E.S. Kilpatrick, B.G. Keevil, A.M. Coady, S.L. Atkin, Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome. Clin. Endocrinol. 70, 233\u2013237 (2009)","journal-title":"Clin. Endocrinol."},{"key":"426_CR22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2265.2007.02888.x","volume":"67","author":"M Sahin","year":"2007","unstructured":"M. Sahin, N. Tanaci, M. Yucel, N.B. Tutuncu, N. Guvener, The effect of single-dose Orlistat on postprandial serum glucose, insulin and glucagon-like peptide-1 levels in nondiabetic obese patients. Clin. Endocrinol. 67, 346\u2013350 (2007)","journal-title":"Clin. Endocrinol."},{"key":"426_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1463-1326.2008.00970.x","volume":"11","author":"S Jacob","year":"2009","unstructured":"S. Jacob, M. Rabbia, M.K. Meier, J. Hauptman, Orlistat 120\u00a0mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes Obes. Metab. 11, 361\u2013371 (2009)","journal-title":"Diabetes Obes. Metab."},{"key":"426_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07315724.2012.10720017","volume":"31","author":"HH Mehrabani","year":"2012","unstructured":"H.H. Mehrabani, S. Salehpour, Z. Amiri, S.J. Farahani, B.J. Meyer, F. Tahbaz, Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. J. Am. Coll. Nutr. 31, 117\u2013125 (2012)","journal-title":"J. Am. Coll. Nutr."},{"key":"426_CR25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-789X.2009.00581.x","volume":"10","author":"K Johansson","year":"2009","unstructured":"K. Johansson, K. Neovius, S.M. DeSantis, S. R\u00f6ssner, M. Neovius, Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obes. Rev. 10, 564\u2013575 (2009)","journal-title":"Obes. Rev."},{"key":"426_CR26","first-page":"451","volume":"26","author":"EG Diaz","year":"2011","unstructured":"E.G. Diaz, T.M. Folgueras, Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents. Nutr. Hosp. 26, 451\u2013457 (2011)","journal-title":"Nutr. Hosp."},{"key":"426_CR27","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/oby.2011.143","volume":"19","author":"SR Smith","year":"2011","unstructured":"S.R. Smith, K.S. Stenlof, F.L. Greenway, J. McHutchison, S.M. Schwartz, V.B. Dev, E.S. Berk, R. Kapikian, Orlistat 60\u00a0mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial. Obesity 19, 1796\u20131803 (2011)","journal-title":"Obesity"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0426-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0426-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0426-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:04Z","timestamp":1559440624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0426-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0426-4","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,8]]}}}